scholarly journals The provision of surgical tracheostomies by maxillofacial surgeons in the UK: time for a dedicated tracheostomy team?

2018 ◽  
Vol 100 (2) ◽  
pp. 116-119
Author(s):  
P Chohan ◽  
R Elledge ◽  
MK Virdi ◽  
GM Walton
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Telephone Survey ◽  
Percutaneous Dilatational Tracheostomy ◽  
Maxillofacial Surgery ◽  
University Hospital ◽  
Oral And Maxillofacial Surgery ◽  
Surgical Tracheostomy ◽  
Surgical Teams ◽  
The Uk

Surgical tracheostomy is a commonly provided service by surgical teams for patients in intensive care where percutaneous dilatational tracheostomy is contraindicated. A number of factors may interfere with its provision on shared emergency operating lists, potentially prolonging the stay in intensive care. We undertook a two-part project to examine the factors that might delay provision of surgical tracheostomy in the intensive care unit. The first part was a prospective audit of practice within the University Hospital Coventry. This was followed by a telephone survey of oral and maxillofacial surgery units throughout the UK. In the intensive care unit at University Hospital Coventry, of 39 referrals, 21 (53.8%) were delayed beyond 24 hours. There was a mean (standard deviation) time to delay of 2.2 days (0.9 days) and the most common cause of delay was surgeon decision, accounting for 13 (61.9%) delays. From a telephone survey of 140 units nationwide, 40 (28.4%) were regularly involved in the provision of surgical tracheostomies for intensive care and 17 (42.5%) experienced delays beyond 24 hours, owing to a combination of theatre availability (76.5%) and surgeon availability (47.1%). There is case for having a dedicated tracheostomy team and provisional theatre slot to optimise patient outcomes and reduce delays. We aim to implement such a move within our unit and audit the outcomes prospectively following this change.

Comparison of Percutaneous Dilatational Tracheostomy with Open Tracheostomy in Intensive Care Unit

2019 ◽  
Vol 41 (1) ◽  
pp. 1-7
Author(s):  
Pramesh S Shrestha ◽  
Moda N Marhatta ◽  
Subhash P Acharya ◽  
Ninadini Shrestha
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Percutaneous Tracheostomy ◽  
Percutaneous Dilatational Tracheostomy ◽  
Hospital Length Of Stay ◽  
Apache Ii Score ◽  
Time Duration ◽  
Surgical Tracheostomy ◽  
Dilatational Tracheostomy ◽  
Emergency Procedures

Introduction: Tracheostomy is one of the frequent surgical procedure carried out in intensive care unit. Percutaneous tracheostomy is becoming increasingly popular compared to conventional open surgical tracheostomy in ICU. Methods: A prospective randomized trial with twenty patients in each group was conducted to compare the outcomes of percutaneous and surgical tracheostomy. Percutaneous tracheostomy was performed using Ciaglia Blue Rhino technique and surgical tracheostomy was performed using established technique. The outcomes were compared in relation to randomization to tracheostomy, completion of procedure, intra operative and post-operative complications, hospital length of stay and cost. Results: There were no major complications in either group. Most variables studied were not statistically significant. The two groups did not differ in terms of basic demographics or APACHE II score. The only variables to reach statistical significance were time duration from tracheostomy randomization to start of procedure and time taken for completion of procedure. It was mean 31.85±15.35 hours in Percutaneous Tracheostomy group and in Surgical Tracheostomy group it was mean 49.10±23.61 hours respectively (p<0.009). Time taken to perform percutaneous tracheostomy was mean 15.50±3.22 minutes and for surgical tracheostomy it was mean 20.30±3.38 minutes. (p<0.001). Conclusion: Percutaneous dilatational tracheostomy is simple, faster to perform and can be done at bedside to avoid considerable delay in the performance of open tracheostomy where there is high demand for elective and emergency procedures in operating room.  

scholarly journals Comparison between Dexmedetomidine and Midazolam for Sedation in Patients with Intubation after Oral and Maxillofacial Surgery

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Li Wang ◽  
Tiejun Zhang ◽  
Lili Huang ◽  
Wei Peng
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Maxillofacial Surgery ◽  
Pain Scale ◽  
Oral And Maxillofacial Surgery ◽  
Midazolam Group ◽  
Significant Difference ◽  
Behavioral Pain Scale ◽  
Random Number Table ◽  
The Difference

The aim of the investigation is to clarify the beneficial sedative effects for patients with postoperative intubation in the intensive care unit (ICU) after oral and maxillofacial surgery. Forty patients with postoperative intubation were divided into two groups in method of random number table: midazolam group and dexmedetomidine group. The Ramsay score, the behavioral pain scale (BPS) score, SpO2, HR, MAP, and RR were recorded before sedation (T0), 30 minutes (T1), 1 hour (T2), 2 hours (T3), 6 hours (T4), and 12 hours (T5) after dexmedetomidine or midazolam initiation in intensive care unit, and 10 minutes after extubation (T6). The rate of incidences of side effects was calculated. Sedation with midazolam was as good as standard sedation with dexmedetomidine in maintaining target sedation level. The BPS score in the midazolam group was higher than that in the dexmedetomidine group. The time of tracheal catheter extraction in the dexmedetomidine group was shorter than that in the midazolam group (p≤0.001). The incidence of bradycardia in the dexmedetomidine group was higher than that in the midazolam group (p=0.028). There was no statistically significant difference in the incidence of hypotension between the two groups (p=0.732). The incidence of respiratory depression of group midazolam was higher than that of group dexmedetomidine (p=0.018). The incidence of delirium in the dexmedetomidine group was significantly lower than that in the midazolam group, and the difference was statistically significant (p=0.003). Dexmedetomidine and midazolam can meet the needs for sedation in ICU patients. And dexmedetomidine can improve patients’ ability to communicate pain compared with midazolam.

scholarly journals Cost Analysis of Open Surgical Bedside Tracheostomy in Intensive Care Unit Patients

2021 ◽  
pp. 014556132110185
Author(s):  
Mats Døving ◽  
Steven Anandan ◽  
Kjetil Gudmundson Rogne ◽  
Tor Paaske Utheim ◽  
Cathrine Brunborg ◽  
...  
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Cost Analysis ◽  
Operating Room ◽  
University Hospital ◽  
Annual Reports ◽  
Complication Rates ◽  
Icu Patients ◽  
Surgical Tracheostomy ◽  
Open Surgical Tracheostomy

Objectives: Open surgical tracheostomy (OST) is a common procedure performed on intensive care unit (ICU) patients. The procedure can be performed bedside in the ICU (bedside open surgical tracheostomy, BeOST) or in the operating room (operating room open surgical tracheostomy, OROST), with comparable safety and long-term complication rates. We aimed to perform a cost analysis and evaluate the use of human resources and the total time used for both BeOSTs and OROSTs. Methods: All OSTs performed in 2017 at 5 different ICUs at Oslo University Hospital Ullevål were retrospectively evaluated. The salaries of the personnel involved in the 2 procedures were obtained from the hospital’s finance department. The time taken and the number of procedures performed were extracted from annual reports and from the electronic patient record system, and the annual expenditures were calculated. Results: Altogether, 142 OSTs were performed, of which 122 (86%) and 20 (14%) were BeOSTs and OROSTs, respectively. A BeOST cost 343 EUR (95% CI: 241.4-444.6) less than an OROST. Bedside open surgical tracheostomies resulted in an annual cost efficiency of 41.818 EUR. In addition, BeOSTs freed 279 hours of operating room occupancy during the study year. Choosing BeOST instead of OROST made 1 nurse, 2 surgical nurses, and 1 anesthetic nurse redundant. Conclusion: Bedside open surgical tracheostomy appears to be cost-, time-, and resource-effective than OROST. In the absence of contraindications, BeOSTs should be performed in ICU patients whenever possible.

scholarly journals Percutaneous Dilatational Tracheostomy and Modifications in Intensive Care Unit Patients

2019 ◽  
Vol 3 (2) ◽  
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Critically Ill Patients ◽  
Safety Profile ◽  
Percutaneous Dilatational Tracheostomy ◽  
Complication Rates ◽  
Surgical Tracheostomy ◽  
Common Indication ◽  
Dilatational Tracheostomy ◽  
Prolonged Ventilation

Percutaneous dilatational tracheostomy (PDT) is a commonly performed procedure in critically ill patients [1]. It can be safely performed bedside. This has resulted in decline in the use of surgical tracheostomy except in few selected cases. Over the last 10 years data on newer methods of insertion, timing, safety profile and complication rates has been published, which has greatly improved our understanding of this procedure [2]. The most common indication of tracheostomy in the ICU is the need for prolonged ventilation. Less complication occur with an increase in skills. Many methods of performing PDT have been discovered recently [3]. Bronchoscopy has been found to be beneficial procedural aides the PDT [4]. In our study, a brief overview about the use of PDT in ICU and, different percutaneous techniques will be discussed. The conclusion is that percutaneous tracheostomies offer benefits for some of the outcomes when compared with surgical tracheostomies.

scholarly journals Percutaneous Dilatational Tracheostomy (PDT) Dini Sebagai Upaya untuk Mencegah Pneumonia dan Mempermudah Perawatan Pasien Stroke di Intensive Care Unit (ICU)

2021 ◽  
Vol 13 (1) ◽  
pp. 31-41
Author(s):  
I Wayan Suryajaya ◽  
Prananda Surya Airlangga ◽  
Eddy Rahardjo
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Basal Ganglia ◽  
Glasgow Coma Scale ◽  
Oral Hygiene ◽  
Guide Wire ◽  
Percutaneous Dilatational Tracheostomy ◽  
Ventilator Associated Pneumonia ◽  
Surgical Tracheostomy ◽  
Dilatational Tracheostomy

Latar Belakang: Stroke atau cerebrovasuler accident (CVA) merupakan hilangnya fungsi-fungsi otak dengan cepat akibat terganggunya suplai darah ke otak. Tidak jarang pasien stroke dirawat di intensive care unit (ICU) karena mengalami gagal napas sehingga membutuhkan ventilator. Kemampuan menelan dan refleks batuk yang tidak adekuat pada pasien stroke sering menyebabkan komplikasi pneumonia/ stroke associated pneumonia (SAP). Komplikasi pneumonia bisa juga disebabkan oleh penggunaan ventilator yang sering disebut ventilator associated pneumonia (VAP). SAP maupun VAP pada pasien stroke dapat dicegah dengan tindakan trakeostomi dini. Percutaneous dilatational tracheostomy (PDT) merupakan teknik trakeostomi dengan melakukan sayatan minimal untuk memasukkan guide wire sebagai panduan. Kemudian lubang trakeostomi diperlebar dengan menggunakan multipel dilator sampai canule trakeostomi bisa masuk ke trakea. PDT lebih mudah dilakukan dibanding surgical tracheostomi sehingga lebih menguntungkan dikerjakan untuk pasien kritis di ICU.Kasus: Terdapat 3 kasus pasien stroke yang dilaporkan dengan glasgow coma scale (GCS) dibawah 8. Kasus pertama: Pasien stroke dengan subakut infark di basal ganglia dekstra dan oedema cerebri. GCS E1V2M1 Pasien mengalami sumbatan partial jalan napas. Pasien dirawat di ICU dan diakukan intubasi. PDT dikerjakan hari ke 2 dengan tujuan untuk mengamankan jalan napas dan mempermudah bronchial toilet sehingga dapat mencegah terjadinya pneumonia.Kasus kedua: pasien stroke dengan infark luas di hemisphere kanan. Pasien dirawat di ICU dengan ventilator. PDT dilakukan pada hari ke 8 untuk mempermudah melakukan fisioterapi napas, bronkial/trakeal toilet. Setelah 50 hari pasien dipindahkan ke ruangan tanpa ditemukan pneumonia.Kasus ketiga: Pasien dengan kesadaran menurun GCS E2V1M3. Pasien dirawat di ICU dengan sumbatan partial jalan napas. PDT dilakukan pada hari pertama dengan tujuan mempertahankan jalan napas tetap aman dan mempermudah tracheal/ bronchial toilet. Pasien dirawat selama 110 hari dan pindah ke ruangan.Pembahasan: Pada ketiga kasus tersebut dilakukan usaha tracheostomi/ PDT secara dini dengan tujuan mengamankan jalan napas tetap bebas, memudahkan oral hygiene dan melakukan fisioterapi napas berupa tracheal/ bronchial toilet. Trakeostomi juga memudahkan mobilisasi pasien sehingga merupakan upaya untuk mencegah terjadinya pneumonia selama perawatan. Selama perawatan pasien tersebut di ICU tidak terjadi komplikasi pneumonia sampai pasien keluar dari ICU. Kesimpulan: Pasien stroke dengan GCS dibawah 8 akan mengalami perawatan yang lama dan potensial terjadi komplikasi berupa SAP maupun VAP bila memakai ventilator. Trakeostomi dini selain mempermudah perawatan dan mempercepat weaning juga sebagai upaya untuk mencegah terjadinya pneumonia. PDT merupakan teknik trakeostomi yang cocok dilakukan untuk pasien kritis di ICU karena lebih menguntungkan dibanding surgical tracheostomy.

scholarly journals Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda

2021 ◽  
pp. 102514
Author(s):  
Abdelilah El Rhalete ◽  
Inas Rhazi ◽  
Amine Bensaid ◽  
Soufiane Diass ◽  
Abderrahim Kaouini ◽  
...  
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Severe Form ◽  
University Hospital

scholarly journals Prevalence of multidrug-resistant Acinetobacter baumannii in a critical care setting: A tertiary teaching hospital experience

2021 ◽  
Vol 9 ◽  
pp. 205031212110011
Author(s):  
Thabit Alotaibi ◽  
Abdulrhman Abuhaimed ◽  
Mohammed Alshahrani ◽  
Ahmed Albdelhady ◽  
Yousef Almubarak ◽  
...  
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Mortality Rate ◽  
Acinetobacter Baumannii ◽  
Care Setting ◽  
Multidrug Resistant ◽  
University Hospital ◽  
Published Data ◽  
Tertiary Teaching ◽  
The Mean

Background: The management of Acinetobacter baumannii infection is considered a challenge especially in an intensive care setting. The resistance rate makes it difficult to manage and is believed to lead to higher mortality. We aim to investigate the prevalence of Acinetobacter baumannii and explore how different antibiotic regimens could impact patient outcomes as there are no available published data to reflect our population in our region. Methods: We conducted a retrospective review of all infected adult patients admitted to the intensive care unit at King Fahad University Hospital with a confirmed laboratory diagnosis of Acinetobacter baumannii from 1 January 2013 until 31 December 2017. Positive cultures were obtained from the microbiology department and those meeting the inclusive criteria were selected. Variables were analyzed using descriptive analysis and cross-tabulation. Results were further reviewed and audited by blinded co-authors. Results: A comprehensive review of data identified 198 patients with Acinetobacter baumannii. The prevalence of Acinetobacter baumannii is 3.37%, and the overall mortality rate is 40.81%. Our sample consisted mainly of male patients, that is, 68.7%, with a mean age of 49 years, and the mean age of female patients was 56 years. The mean age of survivors was less than that of non-survivors, that is, 44.95 years of age. We observed that prior antibiotic use was higher in non-survivors compared to survivors. From the review of treatment provided for patients infected with Acinetobacter baumannii, 65 were treated with colistin alone, 18 were treated with carbapenems, and 22 were treated with a combination of both carbapenems and colistin. The mean length of stay of Acinetobacter baumannii–infected patients was 20.25 days. We found that the survival rates among patients who received carbapenems were higher compared to those who received colistin. Conclusion: We believe that multidrug-resistant Acinetobacter baumannii is prevalent and associated with a higher mortality rate and represents a challenging case for every intensive care unit physician. Further prospective studies are needed.

Sign in / Sign up

Export Citation Format

Share Document